Strong Capital Deployment and Activity
Deployed $91.4 million of capital in Q4 2025 across 24 new commitments (average ~ $3.4M) while realizing ~$148.3 million via repayments and sales.
Dividend Coverage and Supplemental Distribution
Generated net investment income of $13.1M ($0.41 per share) in Q4, covering the $0.36 per share base dividend; paid a $0.43 total dividend including a $0.07 supplemental distribution.
Robust Yield Profile
Weighted average total yield to maturity on debt and income-producing securities was 11.30% (fair value) and 8.15% (amortized cost). New private credit loans funded at a weighted average spread of 453 basis points over the reference rate.
Conservative, Diversified Portfolio Construction
Portfolio fair value ~ $1.2B across 42 industries; 95% senior secured; 10 largest investments represent just 10.9% of the portfolio; average hold size ~$4.7M; average internal rating 3.6.
Low Credit Stress Metrics
Non-accruals remained low: 9 basis points on a fair value basis and 134 basis points on an at-cost basis. PIK income approx. 1.45% of total investment income (well below peers).
Improved Liquidity and Balance Sheet Actions
Available liquidity rose to ~$311.3M (from ~$252.8M prior quarter, ~+23%). Refinanced Wells Fargo facility: tightened spread by ~55 bps, extended maturity to Nov 2030, and increased capacity to $200M (from $175M).
Transparency and Shareholder Returns
Announced January NAV disclosure ($14.48) and remains the only publicly traded BDC with monthly NAV disclosure; Board approved an additional $5M open market share repurchase authorization and declared Q1 2026 base dividend of $0.36 per share.
Market Positioning and Platform Flexibility
Demonstrated ability to participate across private and syndicated tranches (e.g., Hologic ~$75M funded after resizing), highlighting platform flexibility amid evolving deal structures and improving sponsor engagement.